ART'S-WAY MANUFACTURING CO (ARTW)

US0431681032 - Common Stock

1.89  +0 (+0.2%)

Fundamental Rating

1

ARTW gets a fundamental rating of 1 out of 10. The analysis compared the fundamentals against 132 industry peers in the Machinery industry. Both the profitability and financial health of ARTW have multiple concerns. ARTW has a expensive valuation and it also scores bad on growth.



1

1. Profitability

1.1 Basic Checks

In the past year ARTW has reported negative net income.
ARTW had a negative operating cash flow in the past year.
In multiple years ARTW reported negative net income over the last 5 years.
The reported operating cash flow has been mixed in the past 5 years: ARTW reported negative operating cash flow in multiple years.

1.2 Ratios

ARTW has a Return On Assets of -2.20%. This is in the lower half of the industry: ARTW underperforms 71.54% of its industry peers.
ARTW has a Return On Equity of -4.76%. This is in the lower half of the industry: ARTW underperforms 70.00% of its industry peers.
Looking at the Return On Invested Capital, with a value of 2.40%, ARTW is doing worse than 69.23% of the companies in the same industry.
The Average Return On Invested Capital over the past 3 years for ARTW is significantly below the industry average of 10.80%.
Industry RankSector Rank
ROA -2.2%
ROE -4.76%
ROIC 2.4%
ROA(3y)0.84%
ROA(5y)-3.2%
ROE(3y)1.74%
ROE(5y)-5.6%
ROIC(3y)3.24%
ROIC(5y)N/A

1.3 Margins

ARTW has a worse Operating Margin (2.16%) than 70.00% of its industry peers.
ARTW has a Gross Margin (27.41%) which is comparable to the rest of the industry.
ARTW's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 2.16%
PM (TTM) N/A
GM 27.41%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y38.33%
GM growth 5Y9.77%

1

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so ARTW is destroying value.
ARTW has more shares outstanding than it did 1 year ago.
The number of shares outstanding for ARTW has been increased compared to 5 years ago.
ARTW has a worse debt/assets ratio than last year.

2.2 Solvency

An Altman-Z score of 2.31 indicates that ARTW is not a great score, but indicates only limited risk for bankruptcy at the moment.
ARTW has a Altman-Z score (2.31) which is comparable to the rest of the industry.
ARTW has a Debt/Equity ratio of 0.73. This is a neutral value indicating ARTW is somewhat dependend on debt financing.
The Debt to Equity ratio of ARTW (0.73) is worse than 70.00% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.73
Debt/FCF N/A
Altman-Z 2.31
ROIC/WACC0.26
WACC9.28%

2.3 Liquidity

A Current Ratio of 1.51 indicates that ARTW should not have too much problems paying its short term obligations.
With a Current ratio value of 1.51, ARTW is not doing good in the industry: 73.08% of the companies in the same industry are doing better.
ARTW has a Quick Ratio of 1.51. This is a bad value and indicates that ARTW is not financially healthy enough and could expect problems in meeting its short term obligations.
Looking at the Quick ratio, with a value of 0.37, ARTW is doing worse than 93.85% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.51
Quick Ratio 0.37

1

3. Growth

3.1 Past

The earnings per share for ARTW have decreased strongly by -146.93% in the last year.
Looking at the last year, ARTW shows a decrease in Revenue. The Revenue has decreased by -1.97% in the last year.
The Revenue has been growing by 8.95% on average over the past years. This is quite good.
EPS 1Y (TTM)-146.93%
EPS 3YN/A
EPS 5YN/A
EPS growth Q2Q-220.67%
Revenue 1Y (TTM)-1.97%
Revenue growth 3Y10.55%
Revenue growth 5Y8.95%
Revenue growth Q2Q-27.46%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

1

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for ARTW. In the last year negative earnings were reported.
Industry RankSector Rank
PE N/A
Fwd PE N/A

4.2 Price Multiples

76.92% of the companies in the same industry are more expensive than ARTW, based on the Enterprise Value to EBITDA ratio.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 9.59

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

No dividends for ARTW!.
Industry RankSector Rank
Dividend Yield N/A

ART'S-WAY MANUFACTURING CO

NASDAQ:ARTW (5/17/2024, 7:00:01 PM)

1.89

+0 (+0.2%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryMachinery
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap9.58M
Analysts
Price Target
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -2.2%
ROE -4.76%
ROCE
ROIC
ROICexc
ROICexgc
OM 2.16%
PM (TTM) N/A
GM 27.41%
FCFM
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover1.16
Health
Industry RankSector Rank
Debt/Equity 0.73
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio 1.51
Quick Ratio 0.37
Altman-Z
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
Growth
EPS 1Y (TTM)-146.93%
EPS 3YN/A
EPS 5Y
EPS growth Q2Q
EPS Next YN/A
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)-1.97%
Revenue growth 3Y10.55%
Revenue growth 5Y
Revenue growth Q2Q
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y